|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 32706 |
FusionGeneSummary for SBF2_PRMT3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SBF2_PRMT3 | Fusion gene ID: 32706 | Hgene | Tgene | Gene symbol | SBF2 | PRMT3 | Gene ID | 81846 | 10196 |
| Gene name | SET binding factor 2 | protein arginine methyltransferase 3 | |
| Synonyms | CMT4B2|DENND7B|MTMR13 | HRMT1L3 | |
| Cytomap | 11p15.4 | 11p15.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | myotubularin-related protein 13DENN/MADD domain containing 7B | protein arginine N-methyltransferase 3HMT1 hnRNP methyltransferase-like 3heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3 | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q86WG5 | O60678 | |
| Ensembl transtripts involved in fusion gene | ENST00000256190, ENST00000527019, | ENST00000331079, ENST00000437750, | |
| Fusion gene scores | * DoF score | 16 X 9 X 8=1152 | 3 X 2 X 3=18 |
| # samples | 16 | 3 | |
| ** MAII score | log2(16/1152*10)=-2.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: SBF2 [Title/Abstract] AND PRMT3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | PRMT3 | GO:0031397 | negative regulation of protein ubiquitination | 18573314 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LUSC | TCGA-37-4132-01A | SBF2 | chr11 | 10315562 | - | PRMT3 | chr11 | 20473676 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000256190 | ENST00000331079 | SBF2 | chr11 | 10315562 | - | PRMT3 | chr11 | 20473676 | + |
| In-frame | ENST00000256190 | ENST00000437750 | SBF2 | chr11 | 10315562 | - | PRMT3 | chr11 | 20473676 | + |
| intron-3CDS | ENST00000527019 | ENST00000331079 | SBF2 | chr11 | 10315562 | - | PRMT3 | chr11 | 20473676 | + |
| intron-3CDS | ENST00000527019 | ENST00000437750 | SBF2 | chr11 | 10315562 | - | PRMT3 | chr11 | 20473676 | + |
Top |
FusionProtFeatures for SBF2_PRMT3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SBF2 | PRMT3 |
| Methylates (mono and asymmetric dimethylation) theguanidino nitrogens of arginyl residues in some proteins. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | >SBF2 | chr11:10315562 | chr11:20473676 | ENST00000256190 | - | 1 | 40 | 1108_1584 | 18 | 1850 | Domain | Myotubularin phosphatase |
| Hgene | >SBF2 | chr11:10315562 | chr11:20473676 | ENST00000256190 | - | 1 | 40 | 1743_1847 | 18 | 1850 | Domain | PH |
| Hgene | >SBF2 | chr11:10315562 | chr11:20473676 | ENST00000256190 | - | 1 | 40 | 191_324 | 18 | 1850 | Domain | cDENN |
| Hgene | >SBF2 | chr11:10315562 | chr11:20473676 | ENST00000256190 | - | 1 | 40 | 326_427 | 18 | 1850 | Domain | dDENN |
| Hgene | >SBF2 | chr11:10315562 | chr11:20473676 | ENST00000256190 | - | 1 | 40 | 7_172 | 18 | 1850 | Domain | uDENN |
| Hgene | >SBF2 | chr11:10315562 | chr11:20473676 | ENST00000256190 | - | 1 | 40 | 871_957 | 18 | 1850 | Domain | Note=GRAM |
| Tgene | PRMT3 | chr11:10315562 | chr11:20473676 | ENST00000331079 | + | 9 | 16 | 217_531 | 331 | 532 | Domain | SAM-dependent MTase PRMT-type |
| Tgene | PRMT3 | chr11:10315562 | chr11:20473676 | ENST00000437750 | + | 7 | 14 | 217_531 | 269 | 470 | Domain | SAM-dependent MTase PRMT-type |
| Tgene | PRMT3 | chr11:10315562 | chr11:20473676 | ENST00000331079 | + | 9 | 16 | 48_71 | 331 | 532 | Zinc finger | Note=C2H2-type |
| Tgene | PRMT3 | chr11:10315562 | chr11:20473676 | ENST00000437750 | + | 7 | 14 | 48_71 | 269 | 470 | Zinc finger | Note=C2H2-type |
Top |
FusionGeneSequence for SBF2_PRMT3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_SBF2_ENST00000256190_chr11_10315562_-_PRMT3_ENST00000331079_chr11_20473676_+_219aa MARLADYFIVVGYDHEKPGLFSSVXVYVRFCPLCKEQILGKRRLGLPXHLHYQPCSSEXCEXTCXXNCFLGXCLWLQDVLHEESSYSRSC CGSFRSEDSYFRTLWYXAYRLPYDVYLRFGIFIRFYPENHKDIHVHGNCWLLXYIFXEELPQQGRVLYGPSEHQNTLETNSISTGKTIFS >In-frame_SBF2_ENST00000256190_chr11_10315562_-_PRMT3_ENST00000437750_chr11_20473676_+_219aa MARLADYFIVVGYDHEKPGLFSSVXVYVRFCPLCKEQILGKRRLGLPXHLHYQPCSSEXCEXTCXXNCFLGXCLWLQDVLHEESSYSRSC CGSFRSEDSYFRTLWYXAYRLPYDVYLRFGIFIRFYPENHKDIHVHGNCWLLXYIFXEELPQQGRVLYGPSEHQNTLETNSISTGKTIFS |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_SBF2_ENST00000256190_chr11_10315562_-_PRMT3_ENST00000331079_chr11_20473676_+_658nt ATGGCCCGGCTGGCTGACTACTTCATCGTGGTAGGCTATGACCACGAGAAGCCAGGGCTATTTTCTTCTGTTTGAGTCTATGTTAGATTC TGTCCTTTATGCAAAGAACAAATACTTGGCAAAAGGAGGCTCGGTCTACCCTGACATTTGCACTATCAGCCTTGTAGCAGTGAGTGATGT GAATAAACATGCTGATAGAATTGCTTTTTGGGATGATGTCTATGGCTTCAAGATGTCCTGCATGAAGAAAGCAGTTATTCCAGAAGCTGT TGTGGAAGTTTTAGATCCGAAGACTCTTATTTCAGAACCTTGTGGTATTAAGCATATAGATTGCCATACGACGTCTATCTCAGATTTGGA ATTTTCATCAGATTTTACCCTGAAAATCACAAGGACATCCATGTGCACGGCAATTGCTGGCTACTTTGATATATATTTTGAGAAGAATTG CCACAACAGGGTCGTGTTCTCTACGGGCCCTCAGAGCACCAAAACACACTGGAAACAAACAGTATTTCTACTGGAAAAACCATTTTCAGT TAAAGCAGGTGAAGCCTTGAAAGGAAAGGTCACAGTTCACAAGAGTAAGAAAGATCCACGTTCTCTCACCGTGACCCTCACGTTGAATAA >In-frame_SBF2_ENST00000256190_chr11_10315562_-_PRMT3_ENST00000437750_chr11_20473676_+_658nt ATGGCCCGGCTGGCTGACTACTTCATCGTGGTAGGCTATGACCACGAGAAGCCAGGGCTATTTTCTTCTGTTTGAGTCTATGTTAGATTC TGTCCTTTATGCAAAGAACAAATACTTGGCAAAAGGAGGCTCGGTCTACCCTGACATTTGCACTATCAGCCTTGTAGCAGTGAGTGATGT GAATAAACATGCTGATAGAATTGCTTTTTGGGATGATGTCTATGGCTTCAAGATGTCCTGCATGAAGAAAGCAGTTATTCCAGAAGCTGT TGTGGAAGTTTTAGATCCGAAGACTCTTATTTCAGAACCTTGTGGTATTAAGCATATAGATTGCCATACGACGTCTATCTCAGATTTGGA ATTTTCATCAGATTTTACCCTGAAAATCACAAGGACATCCATGTGCACGGCAATTGCTGGCTACTTTGATATATATTTTGAGAAGAATTG CCACAACAGGGTCGTGTTCTCTACGGGCCCTCAGAGCACCAAAACACACTGGAAACAAACAGTATTTCTACTGGAAAAACCATTTTCAGT TAAAGCAGGTGAAGCCTTGAAAGGAAAGGTCACAGTTCACAAGAGTAAGAAAGATCCACGTTCTCTCACCGTGACCCTCACGTTGAATAA |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_SBF2_ENST00000256190_chr11_10315562_-_PRMT3_ENST00000331079_chr11_20473676_+_1636nt GGTTGTCAAACATGGCTGAAGCGCTGCCGCTGCCGCTACTGCCGCTGCAGGGAAAATGCTGAGCCCTCCCGGGCCGGGTGGGCGGCGGCG GCGAGGGCGGCGACGGGGACCCGCTTCCCGAGCGCGGCGGCGGCGGCCATGGCCCGGCTGGCTGACTACTTCATCGTGGTAGGCTATGAC CACGAGAAGCCAGGGCTATTTTCTTCTGTTTGAGTCTATGTTAGATTCTGTCCTTTATGCAAAGAACAAATACTTGGCAAAAGGAGGCTC GGTCTACCCTGACATTTGCACTATCAGCCTTGTAGCAGTGAGTGATGTGAATAAACATGCTGATAGAATTGCTTTTTGGGATGATGTCTA TGGCTTCAAGATGTCCTGCATGAAGAAAGCAGTTATTCCAGAAGCTGTTGTGGAAGTTTTAGATCCGAAGACTCTTATTTCAGAACCTTG TGGTATTAAGCATATAGATTGCCATACGACGTCTATCTCAGATTTGGAATTTTCATCAGATTTTACCCTGAAAATCACAAGGACATCCAT GTGCACGGCAATTGCTGGCTACTTTGATATATATTTTGAGAAGAATTGCCACAACAGGGTCGTGTTCTCTACGGGCCCTCAGAGCACCAA AACACACTGGAAACAAACAGTATTTCTACTGGAAAAACCATTTTCAGTTAAAGCAGGTGAAGCCTTGAAAGGAAAGGTCACAGTTCACAA GAGTAAGAAAGATCCACGTTCTCTCACCGTGACCCTCACGTTGAATAATTCAACTCAAACTTATGGTCTCCAGTGAAACAGCCATAAAAG CACACTACCTTGTAGTTTTTAATGTGGGGGTAGAGTGGGTCAGCAGGAGGGAGCTGGTTTTATGTGAGCAGATGGATGGATGATGGACCC TTTCCTAATGAGCCTCCTCAATAAGAGAGAAGTTCTCATTGTGGGAATCTGACATAGTTCAGCTGAGGAAGAGAATCAGCTGATCCTCAT GGTCTGCCACGTAATCATTTTCTTAGACGTTTGCTCCACCAGATTTAACCAAATGTAACTCCCACATTGAGTTTATCTATATTGAAAATC ATTTACATTGGCCTATATTTGGAAGAGAGATAGTCTTTTGTTTTTAATAAGTTTCTTACTATAAATTTTAAACAAATTGGTTAGTTATTT GGATATTTTATTAAACTAGTAACACAGGTACTACACATTTTATTATGGACTCCTCTGAGGAGGAGTTTTTAATTGTATTTGCTAGAAAAT CAGGATGTAATAAAGATTTGTATAAAAAAACTAAAATATGGAAAAGAGCTTCAGCCTTCATATACAAATCATATATGCAGACAGCCTAGT TGATTATCTAGCATACTTAGGGTTCTCATTTTGTAGTTTCTTCCCTCTTTGTGACTATTCCTTAGCCTTATAGATTTCTAGTACTGCCCA GGAAATCTAATTTCAATACATTTATCCTAGGTTTCATGAAAGTTTTTAAAGATTGGGATAAATATGTACTTATTTACTAACGTATTATCT TTTTCAAACCAGATTTATGTGCAAAGGTTAAACATGTAACTGTTACTAAGCAGTCTATAAAGTTGTCATTTACAATTACTGATTCAATTT >In-frame_SBF2_ENST00000256190_chr11_10315562_-_PRMT3_ENST00000437750_chr11_20473676_+_1091nt GGTTGTCAAACATGGCTGAAGCGCTGCCGCTGCCGCTACTGCCGCTGCAGGGAAAATGCTGAGCCCTCCCGGGCCGGGTGGGCGGCGGCG GCGAGGGCGGCGACGGGGACCCGCTTCCCGAGCGCGGCGGCGGCGGCCATGGCCCGGCTGGCTGACTACTTCATCGTGGTAGGCTATGAC CACGAGAAGCCAGGGCTATTTTCTTCTGTTTGAGTCTATGTTAGATTCTGTCCTTTATGCAAAGAACAAATACTTGGCAAAAGGAGGCTC GGTCTACCCTGACATTTGCACTATCAGCCTTGTAGCAGTGAGTGATGTGAATAAACATGCTGATAGAATTGCTTTTTGGGATGATGTCTA TGGCTTCAAGATGTCCTGCATGAAGAAAGCAGTTATTCCAGAAGCTGTTGTGGAAGTTTTAGATCCGAAGACTCTTATTTCAGAACCTTG TGGTATTAAGCATATAGATTGCCATACGACGTCTATCTCAGATTTGGAATTTTCATCAGATTTTACCCTGAAAATCACAAGGACATCCAT GTGCACGGCAATTGCTGGCTACTTTGATATATATTTTGAGAAGAATTGCCACAACAGGGTCGTGTTCTCTACGGGCCCTCAGAGCACCAA AACACACTGGAAACAAACAGTATTTCTACTGGAAAAACCATTTTCAGTTAAAGCAGGTGAAGCCTTGAAAGGAAAGGTCACAGTTCACAA GAGTAAGAAAGATCCACGTTCTCTCACCGTGACCCTCACGTTGAATAATTCAACTCAAACTTATGGTCTCCAGTGAAACAGCCATAAAAG CACACTACCTTGTAGTTTTTAATGTGGGGGTAGAGTGGGTCAGCAGGAGGGAGCTGGTTTTATGTGAGCAGATGGATGGATGATGGACCC TTTCCTAATGAGCCTCCTCAATAAGAGAGAAGTTCTCATTGTGGGAATCTGACATAGTTCAGCTGAGGAAGAGAATCAGCTGATCCTCAT GGTCTGCCACGTAATCATTTTCTTAGACGTTTGCTCCACCAGATTTAACCAAATGTAACTCCCACATTGAGTTTATCTATATTGAAAATC |
Top |
FusionGenePPI for SBF2_PRMT3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SBF2 | PMS1, UBC, RBPMS, FBXW11, NTRK1, TP53, XPO1, HNRNPD, SORT1, SYNCRIP, BAG6, MTMR2, MTMR1, SBF1, H2AFY2, BAG5, UBA1, FTO, G6PD, AK2, PMPCB, TXNDC12, DCTPP1 | PRMT3 | RPS2, FBL, VHL, TP53, STAT1, VCP, HNRNPA1, PPARD, RASSF2, HIRIP3, IDE, LIG1, ARFIP1, CTNNA1, EIF4B, FAF1, GFPT1, HIST1H4A, HSPH1, NARS, OSBP, PLOD2, SAMHD1, SEC23A, USP11, XRCC5, YAP1, TROVE2, XPO7, EGFR, STX19, FKBP6, PDCD2L, GMPPB, NTRK1, CNTROB, XPO1, HNRNPD, TSC22D2, KLHL10, TSKS, TSHB, TRIM25 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | SBF2 | chr11:10315562 | chr11:20473676 | ENST00000256190 | - | 1 | 40 | 1630_1683 | 18 | 1850 | MTMR2 |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SBF2_PRMT3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SBF2_PRMT3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|